Public Company News

Technical design study on conversion launched

GÖTEBORG, Sweden, Feb. 8, 2022 /PRNewswire/ -- Concordia Maritime has launched a technical design study together with Stena Teknik and a German consulting company specialising in ship design. The aim is to investigate the feasibility of converting and adapting a P-MAX vessel for container transpo...

2022-02-08 16:36 2309

ABB Recognized by Frost & Sullivan for Enabling Optimal Process Optimization and Energy Efficiency with Its Market-leading Electrification of Desalination Solutions

ABB's solutions enhance energy efficiency, augment productivity, improve asset performance, and reduce operational costs of desalination plants. DUBAI, UAE, Feb. 8, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the Gulf Cooperation Council (GCC) electrification of desalination plants i...

2022-02-08 15:00 2957

WuXi Biologics Statement

SHANGHAI, Feb. 8, 2022 /PRNewswire/ -- We have been made aware of a recent U.S. Commerce Department announcement that two WuXi Biologics (Cayman) subsidiaries inShanghai and Wuxi will be added to the department's "Unverified List" (UVL) on February 8, 2022. We understand that the reason for this a...

2022-02-08 11:08 4112

Marina Bay Sands unveils US$1 billion reinvestment to transform luxury travel and hospitality experience

SINGAPORE, Feb. 8, 2022 /PRNewswire/ -- Marina Bay Sands has embarked on a major reinvestment programme for its existing property, spanning hotel rooms and suites, new food and beverage (F&B) offerings and other enhancements that will position the Integrated Resort (IR) for strong growth as the r...

2022-02-08 08:30 4845

Buybacks of series B shares in AB Electrolux during week 05, 2022 - buyback program completed

STOCKHOLM, Feb. 07, 2022 /PRNewswire/ -- During the period January 31 - February 03, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 1,327,560 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimi...

2022-02-07 23:27 2593

SmartKem, Inc. Begins Trading on the OTCQB in the US

Seeking to reshape the world of electronics with a revolutionary new organic semiconductor platform that enables a new generation of displays, sensors and logic MANCHESTER, England, Feb. 7, 2022 /PRNewswire/ -- SmartKem, Inc. (the Company) announced that its common stock has commenced trading on...

2022-02-07 21:27 3652

Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant

* ASC10-A demonstrated strong in vitro antiviral activity against multiple SARS-CoV-2 virus variants including Omicron * By applying a double prodrug strategy, ASC10's permeability in Caco-2 cells and ASC10's oral bioavailability in monkeys were 3.2-fold and 2.3-fold of Molnupiravir, respecti...

2022-02-07 19:00 4384

Invitation to teleconference/audio transmission

GÖTEBORG, Sweden, Feb. 7, 2022 /PRNewswire/ -- Concordia Maritime welcomes you to participate in a teleconference/audio transmission onFebruary 10, 2022 at 3.00 pm CET. The session will feature a presentation of the Financial Statement for the full year 2021 and a Q&A session. Presiding: Erik ...

2022-02-07 18:46 2434

Clarivate Identifies Seven Medtech Trends to Watch in 2022

LONDON, Feb. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report,Outlook on the Medtech Industry: Seven Areas to Watch. The report analyzes seven factors that Clarivate ...

2022-02-07 16:00 2588

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037

SHANGHAI and HONG KONG, Feb. 7, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and o...

2022-02-07 08:30 3962

Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer

SHANGHAI, Feb. 7, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia...

2022-02-07 08:00 5270

Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

* The objectives of the U.S. Phase I trial are to find a recommended Phase II dose and obtain preliminary efficacy in patients with advanced solid tumors * The first U.S. patient is expected to be dosed in the first half of 2022 * ASC61 shows significant antitumor efficacy as a single agent i...

2022-02-06 18:30 5301

Crunchfish Digital Cash for CBDC - with all desired features a Central Bank could ask for

STOCKHOLM, Feb. 4, 2022 /PRNewswire/ -- Crunchfish Digital Cash is ideally suited for retail CBDC as it caters to all desired features that a Central Bank could ever ask for. Crunchfish Digital Cash for CBDC was the topic of the fifth Survival of the fittest webinar onFebruary 4th, 2022. The we...

2022-02-04 22:42 4756

Invitation to the presentation of Elekta's third quarter 2021/22

STOCKHOLM, Feb. 4, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2021/22 at10:00 a.m. CET on February 24. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day. The company's development will be...

2022-02-04 15:57 4178

Nel ASA: Receives contract for containerized electrolyzer and hydrogen refueling equipment

OSLO, Norway, Feb. 4, 2022 /PRNewswire/ -- Nel Hydrogen US, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a contract for a containerized PEM electrolyzer and light duty hydrogen fueling station package from a leading power and gas utility inthe United States. Nel Hydrogen US has received ...

2022-02-04 15:17 3769

L.E.M.O.N. Platform, an Accelerator for the Development of GWM

BAODING, China, Feb. 4, 2022 /PRNewswire/ -- Recently, GWM participated in the Thailand International Motor Expo with its technical achievements on the L.E.M.O.N. Platform to bring a new experience to users around the world. L.E.M.O.N. is a technology platform independently developed by GWM from ...

2022-02-04 14:22 11590

TTI Increasingly Excited about 2022

HONG KONG, Feb. 4, 2022 /PRNewswire/ -- Hong Kong-based global power equipment and floorcare & cleaning companyTechtronic Industries Co. Ltd. ("TTI" or the "Group") (stock code: 669, ADR symbol: TTNDY); We are pleased to announce that we are increasingly excited about our momentum for 2022....

2022-02-04 05:00 7211

JD.com Among FORTUNE 2022 World's Most Admired Companies with Outstanding Social Responsibility Score

BEIJING, Feb. 3, 2022 /PRNewswire/ -- JD.com is ranked on the FORTUNE 2022 World's Most Admired Companies list at No. 6 in the Internet Services and Retailing Category. Other companies listed in the Top 8 industry ranking include Amazon, Alphabet, Xiaomi and more. This is the second time JD.com ...

2022-02-03 23:54 4210

Consistently Bringing Growth to Indonesia, BRI Succeeds with a Profit of Rp. 32,22 Trillion for Q4 2021

JAKARTA, Indonesia, Feb. 3, 2022 /PRNewswire/ -- PT. Bank Rakyat Indonesia (Persero) Tbk (IDX:BBRI)  announced the success of closing 2021 with a profit of Rp.32.22 trillion or grew by 75,53% year on year (yoy) in Q4 2021. The main driver for BRI's profit growth lies in credit performance and the ...

2022-02-03 22:49 7596

Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain*

* Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted)▼ is the first protein-based COVID-19 vaccine authorized inGreat Britain * Novavax and the U.K. Vaccines Taskforce previously announced an agreement for up to 60 million doses * Authorization based on data including an ongoing pivotal Ph...

2022-02-03 21:22 5047
1 ... 788789790791792793794 ... 901